Systematic Financial Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-25,755
Closed -$292K 373
2020
Q2
$292K Buy
25,755
+810
+3% +$9.18K 0.02% 389
2020
Q1
$357K Buy
24,945
+245
+1% +$3.51K 0.02% 256
2019
Q4
$673K Buy
24,700
+6,430
+35% +$175K 0.03% 228
2019
Q3
$523K Sell
18,270
-20,115
-52% -$576K 0.02% 375
2019
Q2
$1.07M Sell
38,385
-1,395
-4% -$38.7K 0.04% 252
2019
Q1
$1.32M Buy
39,780
+1,270
+3% +$42.2K 0.05% 327
2018
Q4
$1.12M Buy
38,510
+8,310
+28% +$241K 0.03% 405
2018
Q3
$1.39M Sell
30,200
-6,890
-19% -$317K 0.03% 400
2018
Q2
$1.39M Sell
37,090
-8,280
-18% -$309K 0.03% 421
2018
Q1
$1.34M Buy
45,370
+2,380
+6% +$70.3K 0.03% 472
2017
Q4
$1.48M Sell
42,990
-3,435
-7% -$118K 0.03% 410
2017
Q3
$1.68M Sell
46,425
-21,885
-32% -$792K 0.03% 318
2017
Q2
$1.77M Sell
68,310
-30,910
-31% -$799K 0.03% 399
2017
Q1
$1.91M Sell
99,220
-1,755
-2% -$33.7K 0.03% 355
2016
Q4
$1.68M Buy
100,975
+15,305
+18% +$255K 0.03% 479
2016
Q3
$1.76M Buy
85,670
+33,060
+63% +$680K 0.02% 408
2016
Q2
$1.61M Buy
+52,610
New +$1.61M 0.02% 472
2015
Q3
Sell
-71,283
Closed -$2.42M 682
2015
Q2
$2.42M Buy
71,283
+6,912
+11% +$235K 0.02% 526
2015
Q1
$2.28M Sell
64,371
-4,970
-7% -$176K 0.02% 532
2014
Q4
$2.36M Buy
69,341
+3,355
+5% +$114K 0.02% 427
2014
Q3
$2.55M Buy
65,986
+11,185
+20% +$431K 0.02% 399
2014
Q2
$2.13M Sell
54,801
-3,205
-6% -$125K 0.01% 397
2014
Q1
$1.98M Sell
58,006
-59,533
-51% -$2.04M 0.01% 418
2013
Q4
$2.47M Sell
117,539
-2,156,575
-95% -$45.2M 0.02% 375
2013
Q3
$53.4M Buy
2,274,114
+224,025
+11% +$5.26M 0.42% 78
2013
Q2
$55.1M Buy
+2,050,089
New +$55.1M 0.47% 70